Follow
David Huntsman
David Huntsman
Verified email at bccancer.bc.ca
Title
Cited by
Cited by
Year
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
67672011
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
42872018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
24942018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
23742018
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...
Nature 486 (7403), 395-399, 2012
22562012
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
21052018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
19762018
ARID1A mutations in endometriosis-associated ovarian carcinomas
KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ...
New England Journal of Medicine 363 (16), 1532-1543, 2010
18792010
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1641*2020
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
15272018
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non …
KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ...
The lancet oncology 12 (9), 852-861, 2011
13202011
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ...
Nature 461 (7265), 809-813, 2009
13172009
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 …
FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ...
PLoS medicine 7 (5), e1000279, 2010
12392010
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
11182015
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ...
The lancet oncology 13 (4), 385-394, 2012
10692012
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
C Tognon, SR Knezevich, D Huntsman, CD Roskelley, N Melnyk, ...
Cancer cell 2 (5), 367-376, 2002
9752002
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies
M Köbel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer, S Leung, ...
PLoS medicine 5 (12), e232, 2008
9522008
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
8932018
Mutation of FOXL2 in granulosa-cell tumors of the ovary
SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ...
New England Journal of Medicine 360 (26), 2719-2729, 2009
8472009
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
8242018
The system can't perform the operation now. Try again later.
Articles 1–20